- Home
- WOK vs RAPT Comparison
WOK vs RAPT Comparison
Compare WOK & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOK
- RAPT
- Stock Information
- Founded
- WOK 2002
- RAPT 2015
- Country
- WOK China
- RAPT United States
- Employees
- WOK N/A
- RAPT N/A
- Industry
- WOK
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- WOK
- RAPT Health Care
- Exchange
- WOK NYSE
- RAPT Nasdaq
- Market Cap
- WOK 70.3M
- RAPT 59.1M
- IPO Year
- WOK 2024
- RAPT 2019
- Fundamental
- Price
- WOK $1.07
- RAPT $1.25
- Analyst Decision
- WOK
- RAPT Hold
- Analyst Count
- WOK 0
- RAPT 10
- Target Price
- WOK N/A
- RAPT $6.00
- AVG Volume (30 Days)
- WOK 6.1M
- RAPT 627.1K
- Earning Date
- WOK 02-03-2025
- RAPT 03-06-2025
- Dividend Yield
- WOK N/A
- RAPT N/A
- EPS Growth
- WOK N/A
- RAPT N/A
- EPS
- WOK N/A
- RAPT N/A
- Revenue
- WOK $11,506,440.00
- RAPT N/A
- Revenue This Year
- WOK N/A
- RAPT N/A
- Revenue Next Year
- WOK N/A
- RAPT N/A
- P/E Ratio
- WOK N/A
- RAPT N/A
- Revenue Growth
- WOK N/A
- RAPT N/A
- 52 Week Low
- WOK $0.85
- RAPT $0.79
- 52 Week High
- WOK $8.45
- RAPT $10.05
- Technical
- Relative Strength Index (RSI)
- WOK N/A
- RAPT 53.72
- Support Level
- WOK N/A
- RAPT $1.10
- Resistance Level
- WOK N/A
- RAPT $1.30
- Average True Range (ATR)
- WOK 0.00
- RAPT 0.09
- MACD
- WOK 0.00
- RAPT 0.02
- Stochastic Oscillator
- WOK 0.00
- RAPT 72.00
About WOK WORK MEDICAL TECHNOLOGY GROUP LTD
WORK Medical Technology Group Ltd is a manufacturer of medical devices, and it is committed to providing professional and reliable medical devices to the world.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.